Coronary artery disease: optimal lipoprotein(a) for survival—lower is better? A large cohort with 43,647 patients (Frontiers in Cardiovascular Medicine, 2021)

(untitled) - Liu, J; Liu, L; Wang, B; Chen, S; Liu, B; Liang, J; Huang, H; Li, Q; Lun, Z; Ying, M; Chen, G; Huang, Z; et al.